Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice

Domenico De Berardis*, Michele Fornaro, Laura Orsolini, Felice Iasevoli, Carmine Tomasetti, Andrea de Bartolomeis, Nicola Serroni, Ida De Lauretis, Gabriella Girinelli, Monica Mazza, Alessandro Valchera, Alessandro Carano, Federica Vellante, Ilaria Matarazzo, Giampaolo Perna, Giovanni Martinotti, Massimo Di Giannantonio

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)342-347
Number of pages6
JournalCns Spectrums
Volume22
Issue number4
DOIs
Publication statusPublished - Aug 2017

Keywords

  • Agomelatine
  • anhedonia
  • C-reactive protein
  • inflammation
  • major depressive disorder
  • remission
  • response
  • TREATMENT RESPONSE
  • INFLAMMATION
  • CYTOKINE
  • EFFICACY
  • ANTIDEPRESSANTS
  • PATHOPHYSIOLOGY
  • TOLERABILITY
  • MECHANISM
  • ANXIETY
  • BALANCE

Cite this

De Berardis, D., Fornaro, M., Orsolini, L., Iasevoli, F., Tomasetti, C., de Bartolomeis, A., Serroni, N., De Lauretis, I., Girinelli, G., Mazza, M., Valchera, A., Carano, A., Vellante, F., Matarazzo, I., Perna, G., Martinotti, G., & Di Giannantonio, M. (2017). Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice. Cns Spectrums, 22(4), 342-347. https://doi.org/10.1017/S1092852916000572